Mabion S.A. (MAB) - Net Assets

Latest as of March 2026: zł39.09 Million PLN ≈ $10.76 Million USD

Based on the latest financial reports, Mabion S.A. (MAB) has net assets worth zł39.09 Million PLN (≈ $10.76 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (zł109.85 Million ≈ $30.23 Million USD) and total liabilities (zł70.76 Million ≈ $19.47 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check MAB goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	zł39.09 Million
% of Total Assets	35.59%
Annual Growth Rate	N/A
5-Year Change	-8.41%
10-Year Change	1209.41%
Growth Volatility	2530.37

Mabion S.A. - Net Assets Trend (2009–2025)

This chart illustrates how Mabion S.A.'s net assets have evolved over time, based on quarterly financial data. See Mabion S.A. defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Mabion S.A. (2009–2025)

The table below shows the annual net assets of Mabion S.A. from 2009 to 2025. For live valuation and market cap data, see MAB market cap overview.

Year	Net Assets	Change
2025-12-31	zł48.83 Million ≈ $13.44 Million	-56.19%
2024-12-31	zł111.44 Million ≈ $30.67 Million	-5.38%
2023-12-31	zł117.78 Million ≈ $32.41 Million	+53.94%
2022-12-31	zł76.51 Million ≈ $21.06 Million	+43.51%
2021-12-31	zł53.31 Million ≈ $14.67 Million	+168.89%
2020-12-31	zł-77.39 Million ≈ $-21.30 Million	-258.61%
2019-12-31	zł-21.58 Million ≈ $-5.94 Million	-151.21%
2018-12-31	zł42.14 Million ≈ $11.60 Million	+177.81%
2017-12-31	zł-54.16 Million ≈ $-14.91 Million	-1552.35%
2016-12-31	zł3.73 Million ≈ $1.03 Million	-97.08%
2015-12-31	zł127.64 Million ≈ $35.13 Million	-87.21%
2014-12-31	zł997.84 Million ≈ $274.62 Million	+91.69%
2013-12-31	zł520.55 Million ≈ $143.26 Million	-71.47%
2012-12-31	zł1.82 Billion ≈ $502.09 Million	+8858.29%
2011-12-31	zł20.37 Million ≈ $5.60 Million	-6.23%
2010-12-31	zł21.72 Million ≈ $5.98 Million	+29137.19%
2009-12-31	zł-74.80K ≈ $-20.59K	--

Equity Component Analysis

This analysis shows how different components contribute to Mabion S.A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 21284820202.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Other Components	zł262.25 Million	537.09%
Total Equity	zł48.83 Million	100.00%

Mabion S.A. Competitors by Market Cap

The table below lists competitors of Mabion S.A. ranked by their market capitalization.

Company	Market Cap
Hanwha Chemical Corp Pref KO:009835	$34.83 Million
TechPrecision Corporation Common stock NASDAQ:TPCS	$34.84 Million
US Energy Corp NASDAQ:USEG	$34.85 Million
Seplat Petroleum Development Company PLC LSE:SEPL	$34.86 Million
INmune Bio Inc NASDAQ:INMB	$34.83 Million
Culp, Inc. Common Stock NYSE:CULP	$34.82 Million
Dunia Virtual Online Tbk Pt JK:AREA	$34.82 Million
Otto Holding AS IS:OTTO	$34.82 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Mabion S.A.'s equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 111,442,000 to 48,828,000, a change of -62,614,000 (-56.2%).
Net loss of 62,614,000 reduced equity.
Other comprehensive income decreased equity by 23,192,000.
Other factors increased equity by 23,192,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	zł-62.61 Million	-128.23%
Other Comprehensive Income	zł-23.19 Million	-47.5%
Other Changes	zł23.19 Million	+47.5%
Total Change	zł-	-56.19%

Book Value vs Market Value Analysis

This analysis compares Mabion S.A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 2.59x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2009-12-31	zł-0.01	zł7.83	x
2010-12-31	zł3.15	zł7.83	x
2011-12-31	zł4.17	zł7.83	x
2012-12-31	zł342.28	zł7.83	x
2013-12-31	zł65.64	zł7.83	x
2014-12-31	zł99.20	zł7.83	x
2015-12-31	zł11.73	zł7.83	x
2016-12-31	zł0.32	zł7.83	x
2017-12-31	zł-4.59	zł7.83	x
2018-12-31	zł3.22	zł7.83	x
2019-12-31	zł-1.57	zł7.83	x
2020-12-31	zł-5.64	zł7.83	x
2021-12-31	zł3.43	zł7.83	x
2022-12-31	zł4.73	zł7.83	x
2023-12-31	zł7.29	zł7.83	x
2024-12-31	zł6.90	zł7.83	x
2025-12-31	zł3.02	zł7.83	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Mabion S.A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -128.23%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -397.37%
• Asset Turnover: 0.14x
• Equity Multiplier: 2.26x
Recent ROE (-128.23%) is below the historical average (-102.05%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2009	0.00%	0.00%	0.00x	0.00x	zł-321.27K
2010	2.17%	30.86%	0.07x	1.08x	zł-1.70 Million
2011	-6.65%	-137.41%	0.04x	1.32x	zł-3.39 Million
2012	-0.12%	-239.77%	0.00x	2.17x	zł-184.56 Million
2013	-0.75%	-67089.66%	0.00x	1.45x	zł-55.95 Million
2014	-0.45%	-537.69%	0.00x	1.48x	zł-104.25 Million
2015	-3.60%	-168.20%	0.01x	1.52x	zł-17.36 Million
2016	-1497.08%	0.00%	0.00x	24.47x	zł-56.20 Million
2017	0.00%	0.00%	0.00x	0.00x	zł-52.47 Million
2018	-163.44%	0.00%	0.00x	3.43x	zł-73.08 Million
2019	0.00%	0.00%	0.00x	0.00x	zł-62.55 Million
2020	0.00%	-3596.73%	0.02x	0.00x	zł-49.45 Million
2021	3.57%	3.35%	0.31x	3.46x	zł-3.43 Million
2022	30.31%	14.14%	0.88x	2.43x	zł15.54 Million
2023	35.04%	27.21%	0.73x	1.77x	zł29.49 Million
2024	-5.68%	-9.18%	0.43x	1.43x	zł-17.48 Million
2025	-128.23%	-397.37%	0.14x	2.26x	zł-67.50 Million

Industry Comparison

This section compares Mabion S.A.'s net assets metrics with peer companies in the Biotechnology industry.

Industry Context

Industry: Biotechnology
Average net assets among peers: $121,057,376
Average return on equity (ROE) among peers: -49.00%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Mabion S.A. (MAB)	zł39.09 Million	0.00%	1.81x	$34.83 Million
Bioton S.A. (BIO)	$886.79 Million	3.00%	0.74x	$94.05 Million
Captor Therapeutics S.A. (CTX)	$96.32 Million	-37.26%	0.17x	$115.98 Million
Molecure S.A. (MOC)	$13.01 Million	-18.64%	0.19x	$32.21 Million
Nanogroup SA (NNG)	$8.37 Million	-119.60%	1.43x	$20.32 Million
Pharmena S.A. (PHR)	$16.45 Million	3.70%	0.10x	$9.72 Million
PolTREG S.A. (PTG)	$-6.00K	0.00%	0.00x	$24.13 Million
Pure Biologics Spólka Akcyjna (PUR)	$18.30 Million	-144.13%	0.80x	$7.86 Million
Ryvu Therapeutics SA (RVU)	$5.53 Million	-116.19%	1.77x	$90.23 Million
Synthaverse S.A. (SVE)	$44.75 Million	-11.87%	1.10x	$56.30 Million

About Mabion S.A.

WAR:MAB Poland Biotechnology

Market Cap

$34.83 Million

zł126.55 Million PLN

Market Cap Rank

#23301 Global

#221 in Poland

Share Price

zł7.83

Change (1 day)

+4.96%

52-Week Range

zł6.82 - zł10.10

All Time High

zł134.60